valtrex maximum dosage
Prevention of Herpes Zoster, Varicella zoster caused by virus, after an initial period of use of Valtrex for parenteral use in all patients with impaired immunity (including after transplantation and immunosuppressive drugs, HIV-infected patients, on a background of chemotherapy)-inside;
Herpes Zoster eye-defeat inwards parenteral;
generalized infection of infants caused by the virus Herpes simplex-dropped;
chickenpox in patients with nenarushennym immunity within 24 h after the onset of typical rash-inside, in patients with impaired immunity is dropped.
Possible substitutes for the drug Valtrex:
Valtrex-AGOS (from 19.00 USD), Valtrex-Acre (from 22.00 USD), Valtrex Belupo (from 42.00 USD), Gerperaks (from 51.00 USD), Vivoraks (from 58.00 USD). Show all
Note: the use of substitutes must be agreed with the doctor. Active substance group:
Valtrex (Aciclovir), antiviral agent
capsules, extract for solution for the infusions, oral suspension, tablets, instant
Valtrex cream for external use ointment, eye ointment for external use
Hypersensitivity (including valatzikloviru). (C) caution. Pregnancy, lactation period.
For the on/in the introduction (optional)-kidney failure (risk nefrotoksicski action), dehydration, neurological disorders or neurological reactions to receiving cytotoxic PP (incl. history). normal kidney function, CHRI QC more than 25 mL/min-800 mg every 4 h during waking hours, 5 times a day, Qc 10-25 mL/min-800 mg every 8 h, CC less than 10 mL/min-800 mg every 12:00
Children up to 2 years of age-the dose is not determined. However, when examining the drug no unusual toxicity or specials
Anaphylactic reactions, allergic skin reaction (itching, rash, laiella syndrome, urticaria, Erythema ekssoudatus Erythema, including Stevens-Johnson Syndrome), sputannosti consciousness, increased activity of "liver" transaminaz, fever, hallucinations, leukopenia, Lymphadenopathy, peripheral oedema, impaired vision, headache.
Only for injecting: phlebitis, or inflammation at the injection, acute renal failure, signs of encephalopathy (coma, sputannosti consciousness, hallucinations, convulsions, tremor), hematologic (anemia, leukocytosis, neutropenia or neutrophilia, or trombozitos thrombocytopenia), gematuria, DVS-sindrom, hemolysis, a decline ad, mental disorders (including delirium), depressed condition or psychosis, impaired gastrointestinal (reduced appetite, nausea, vomiting), increased urea nitrogen and gipercreatininemia (due to obstruction of the renal tubules; typically, when properly selected dose and adequate flow of fluid increase not stated).
Only the ingestion: malaise, impaired gastrointestinal (nausea, vomiting, diarrhea, abdominal pain), psychomotor agitation, alopecia, dizziness, myalgia, paresthesia, somnolence. Overdose. Oral intake of 20 grams of Valtrex did not lead to the development of specific symptoms.
In injecting application (when bolusnom or used in high doses or in patients who have not adequately controlled vodno-elektrolitny balance): improvement of urea nitrogen, gipercreatininemia, violation of the kidney, lethargy, convulsions, coma.
Treatment: maintaining vital functions, Hepatology.
valtrex maximum dosageSpecial instructions:
Prolonged or repeated treatment with Valtrex patients with low immunity could lead to strains of viruses, sensitive to its effects. The majority of selected strains of viruses, insensitive to azikloviru encounters a relative lack of viral timidinkinaza virus; There were strains with modified timidinkinazoy or with altered DNA polymerase. In vitro effect of Valtrex on isolated strains of Herpes simplex virus can cause less sensitive strains.
Adequate and well-controlled clinical studies safety of the drug during pregnancy is not held. Use is shown only in cases where the presumed benefit to the mother outweighs the potential risk to the fetus.
During therapy high oral doses of drugs should ensure adequate intake of fluids in the organism of the patient.
If necessary, the appointment of the drug during lactation should stop breastfeeding.
Valtrex does not prevents transmission of herpes infections during treatment should therefore abstain from sexual contact, even in the absence of clinical manifestations.
When mixing solutions must take into account the alkaline reaction of Valtrex for the on/in the introduction (pH 11).
Enhancing effect noted while appointing immunostimulators.
Blockers reduce kanalzeva secreta kanalzevu secretion in/typed Valtrex, which can lead to increased concentrations of Valtrex in the serum and CSF, slow excretion aziklovira (increase in the T1/2) of blood and CSF, enhance toxicity.
Etc. nefrotoksicskie HP-increased risk of nefrotoksicski action.